Show Summary Details

Quick Reference


a third-generation analogue of cisplatin that is administered by intravenous infusion in the treatment of gastrointestinal malignancies, particularly colorectal cancer. It has less toxic side-effects than cisplatin. Trade name: Eloxatin.

Subjects: Clinical Pharmacology and Therapeutics.

Reference entries

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.